Barclays’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-11,756	Closed	-$105K	–	4546
2013 Q4	$105K	Sell	11,756 -3,578	-23%	-$32K	﹤0.01%	3014
2013 Q3	$92K	Sell	15,334 -20,046	-57%	-$120K	﹤0.01%	2982
2013 Q2	$241K	Buy	+35,380	New	+$241K	﹤0.01%	2590